Autoimmune Hemolytic Anemia during Adalimumab Treatment for Plaque Psoriasis
Author:
Affiliation:
1. Nagano Chuo Hospital, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Reference8 articles.
1. 1. Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP. Adalimumab: long-term safety in 23458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis 72: 517-524, 2013.
2. 2. Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23 (Suppl 2): 1-70, 2009.
3. 3. Casanova MJ, Chaparro M, Martínez S, Vicuña I, Gisbert JP. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease. J Crohns Colitis 6: 1034-1037, 2012.
4. 4. Ottaviani S, Cerf-Payrastre I, Kemiche F, Pertuiset E. Adalimumab-induced neutropenia in a patient with rheumatoid arthritis. Joint Bone Spine 76: 312-313, 2009.
5. 5. Watanabe K, Watanabe R, Shioda A, Mizoguchi K, Sugimoto T, Terao K. Investigation of the mechanism of drug-induced autoimmune hemolytic anemia in cynomolgus monkeys elicited by a repeated-dose of a humanized monoclonal antibody drug. J Toxicol Sci 28: 123-138, 2003.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol;Pathology and Oncology Research;2024-05-23
2. Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice;Journal of Dermatological Treatment;2023-05-29
3. Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence;Annals of Hematology;2022-06-27
4. Autoimmune Hemolytic Anemia After mRNA COVID Vaccine;Journal of Investigative Medicine High Impact Case Reports;2022-01
5. An Uncharacteristic Presentation of Evans Syndrome Following Treatment With Dupilumab;Cureus;2021-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3